Both MACs later rescinded their final decisions and reposted them as draft LCDs with a two-month public comment period. Many of the comments expressed concern that the new coverage criteria would ...

Neurocrine Biosciences (Nasdaq: NBIX) has announced the appointment of Andrew Ratz as senior VP of drug development, supporting the firm’s expanding R&D efforts. Dr Ratz brings nearly three decades of ...